R&D

Dr. B.R. Ambedkar Center for Biomedical Research (ACBR) was established in March 1991 as part of Centenary celebrations of Baba Saheb Dr. B.R. Ambedkar and its foundation stone was laid by the Hon'ble Prime Minister of India Sh. Chander Shekhar Ji on 31 st March 1991.The mandate of the Centre is postgraduate education and research in Biomedical Sciences.

The CSIR, established in 1942 with Corporate Office at New Delhi, and a network of 38 national laboratories spread over the country is a premier R & D Organisation in India providing S & T inputs to a diverse spectrum of economic, industrial and societal sectors. The R & D activities covers fields from aerospace engineering to ocean sciences, molecular biology to metallurgy, chemicals to mining, food to petroleum & leather to environment.

The Tata Memorial Hospital was initially commissioned by the Sir Dorabji Tata Trust on 28 February 1941 as a center with enduring value and a mission for concern for the Indian people.

Nectar Lifesciences Ltd (NecLife) is a 200 million US$ integrated pharmaceutical organization, offering comprehensive range of Cephalosporin Active Pharmaceutical Ingredients and Finished Dosage Forms. The development and manufacture of quality intermediates, bulk actives have been critical to our success to become one of the largest manufacturers of cephalosporin range of products and delivering innovative and affordable products to domestic as well as international markets.

Emcure are fortunate to have a very passionate and talented team. Emcure is committed to emerge as the most preferred employer. We have conducted several training programs and also taken policy decisions towards creating a better work life balance for our people.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.

Indian Institute of Technology – Roorkee is among the foremost of institutes of national importance in higher technological education and in engineering, basic and applied research.

Glenmark Pharmaceuticals today announced the settlement of litigation with Daiichi Sankyo and Genzyme Corporation regarding Glenmark's Abbreviated New Drug Application (ANDA) tiled with the US Food and Drug Administration (FDA) for Colesevelam Hydrochloride, a drug used in treatment of type-2 diabetes.